Original ResearchImmune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
Under a Creative Commons license
open access
Central Illustration
Key Words
BNP
cardiotoxicity
immune checkpoint inhibitors
lung cancer
MACE
troponin
Abbreviations and Acronyms
BNP
B-type natriuretic peptide
CI
confidence interval
HR
hazard ratio
ICI
immune checkpoint inhibitor
IQR
interquartile range
LVEF
left ventricular ejection fraction
MACE
major adverse cardiovascular events
PD
programmed cell death protein
PD-L1
programmed cell death-ligand 1
TKI
tyrosine kinase inhibitor
TnI
troponin I
VEGFI
vascular endothelial growth factor inhibitor
Cited by (0)
Dr. Bhimaraj has been a consultant for Abbott and Abiomed. Dr. Bernicker has served on an advisory board for Guardant Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.